AF
ASTH icon

Amalgamated Financial’s Astrana Health ASTH Stock Holding History

Amalgamated Financial’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$898K Buy
+18,521
New +$955K 0.01% 1223

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Amalgamated Financial's ASTH Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Astrana Health (ASTH) in Q1 2022: 18,521 shares worth $898K. The stake represents 0.01% of the portfolio and ranks #1223 among its holdings.

139 funds tracked by Wall St. Rank hold ASTH as of Q1 2022.

  • Amalgamated Financial held 18,521 shares of Astrana Health worth $898K as of Q1 2022.
  • Astrana Health was a new Amalgamated Financial position in Q1 2022.
  • Astrana Health made up 0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1223 holding.
  • 139 funds tracked by Wall St. Rank held Astrana Health as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.